News

Therma Bright Ships Initial Venowave Order to US Distributor

Toronto, Ontario--(Newsfile Corp. - April 28, 2022) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical…

2 years ago

Psychedelic Research Company Lophos Pharmaceuticals Corp. Developing Sustainably-Grown Peyote in Canada

Toronto, Ontario--(Newsfile Corp. - April 28, 2022) - Lophos Pharmaceuticals Corp., Lophos is a Canadian psychedelic research company focused on…

2 years ago

Emerald Health Therapeutics, Inc. Applies for Management Cease Trade Order

Vancouver, British Columbia--(Newsfile Corp. - April 28, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald" or the "Company")…

2 years ago

Tesseract Health Appoints Dr. Michael McConnell as Head of Cardiovascular and Digital Health

Former Google Health Executive to Expand Cardiovascular Strategy for Ocular Health Technology Company GUILFORD, Conn.--(BUSINESS WIRE)--Tesseract Health, a health technology…

2 years ago

Establishment Labs to Announce First Quarter 2022 Financial Results on May 9

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and…

2 years ago

IDC MarketScape Positions Accenture a Leader in Life Science Sales and Marketing IT Outsourcing Services

Accenture is recognized by its customers for its technical capabilities and life science industry expertise NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN)…

2 years ago

Titan Medical to Issue First Quarter 2022 Financial Results on May 12, 2022

TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today…

2 years ago

Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over Year

FY 2022 Annual Revenue of $1.032 billion, Up 22% Versus Prior Year DANVERS, Mass.--(BUSINESS WIRE)--ABIOMED, Inc. (NASDAQ: ABMD), a leader…

2 years ago

Evaluate report signals orphan drug market is niche no more

London, UK – 28 April 2022 – Evaluate, the leading provider of market intelligence and predictive analytics for the pharmaceutical…

2 years ago

Panacea Life Sciences Establishes Scientific Advisory Board Dedicated to Cannabinoid Science Research to Support Clinical Strategy and Product Development

GOLDEN, CO / ACCESSWIRE / April 28, 2022 / Panacea Life Sciences, Inc. (OTCQB:PLSH), ("Panacea" or the "Company"), a Colorado,…

2 years ago